Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2815
H.R.2815: BIOSIM Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced April 22, 2021
- Latest Major Action April 23, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
4 (3 Democrats, 1 Republican)
Bill Version
- Introduced in House - April 22, 2021
Bill Summary
Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
April 23, 2021 |
Referred to the Subcommittee on Health.
|
April 22, 2021 |
Referred to the Subcommittee on Social Security.
|
April 22, 2021 |
Referred to the Subcommittee on Health.
|
April 22, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
April 22, 2021 |
Introduced in the House by Kurt Schrader (D-Ore.) |